Source: BioPortfolio

CombiMatrix: CombiMatrix Corp CBMX Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 16042018 Prices from USD $250

SummaryCombiMatrix Corp CombiMatrix is a provider of molecular diagnostic solutions specializing in cytogenomic testing for prenatal diagnosis miscarriage analysis and pediatric developmental disorders. It offers DNAbased testing services for the detection...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Mark McDonough's photo - President & CEO of CombiMatrix

President & CEO

Mark McDonough

CEO Approval Rating

73/100

Read more